Amryt to Report Q3 2021 Results and Host Conference Call & Webcast on November 3
October 20, 2021 07:00 ET
|
Amryt Pharma plc
Amryt to Report Q3 2021 Results and Host Conference Call & Webcast on November 3 DUBLIN, Ireland, and Boston MA, October 20, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
Amryt Announces New Patents for Oleogel-S10 and Mycapssa®
October 19, 2021 07:00 ET
|
Amryt Pharma plc
Amryt Announces New Patents for Oleogel-S10 and Mycapssa® DUBLIN, Ireland, and Boston MA, October 19, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company...
Total Voting Rights
October 01, 2021 02:00 ET
|
Amryt Pharma plc
Total Voting Rights DUBLIN, Ireland, and Boston MA, October 1, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and...
Amryt Raises Full Year 2021 Revenue Guidance to $220M - $225M
September 13, 2021 07:00 ET
|
Amryt Pharma plc
Amryt Raises Full Year 2021 Revenue Guidance to $220M - $225M Representing 20% - 23% YoY growth Virtual Capital Markets Event today at 1000-1200 EDT DUBLIN, Ireland, and Boston MA, September...
Total Voting Rights
September 01, 2021 02:00 ET
|
Amryt Pharma plc
Total Voting Rights DUBLIN, Ireland, and Boston MA, September 1, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and...
Amryt Issues Ordinary Shares and Total Voting Rights
August 19, 2021 02:00 ET
|
Amryt Pharma plc
Amryt Issues Ordinary Shares and Total Voting Rights DUBLIN, Ireland, and Boston MA, August 19, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated...
Director/PDMR Shareholding
August 10, 2021 09:20 ET
|
Amryt Pharma plc
Director / PDMR Disclosure Options Granted to Non-Executive Directors DUBLIN, Ireland, and Boston MA, August 10, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
Amryt Virtual Capital Markets Event - September 13, 2021 – 1000-1200 EDT
August 09, 2021 07:00 ET
|
Amryt Pharma plc
Amryt Virtual Capital Markets Event - September 13, 2021 – 1000-1200 EDT DUBLIN, Ireland, and Boston MA, August 9, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
August 06, 2021 07:00 ET
|
Amryt Pharma plc
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance Acquisition of Chiasma completed Amryt now has three approved commercial products and a robust clinical pipeline 35.9% YoY revenue...
Amryt Successfully Completes Acquisition of Chiasma, Inc., Board Appointments, Issues Ordinary Shares and Total Voting Rights
August 05, 2021 10:50 ET
|
Amryt Pharma plc
Amryt Successfully Completes Acquisition of Chiasma, Inc. Appoints Raj Kannan and Dr. Roni Mamluk as Non-Executive Directors Issues Ordinary Shares and Total Voting Rights DUBLIN, Ireland, and...